X0206 3 2015-03-04 0 0001447028 TEKMIRA PHARMACEUTICALS Corp TKMR 0001635075 Ramaswamy Vivek C/O TEKMIRA PHARMACEUTICALS CORPORATION 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 1 0 1 0 Common Stock 54915 D Common Stock 16013540 I By Corporation The reporting person held 54,530 shares of common stock of OnCore Biopharma, Inc. ("OnCore"). Pursuant to that certain Agreement and Plan of Merger and Reorganization, dated January 11, 2015, by and among the issuer, TKM Acquisition Corporation and OnCore (the "Merger"), each issued and outstanding share of OnCore common stock was converted into 1.007062 common shares (rounded down) of the issuer. The closing of the Merger occurred on March 4, 2015. These shares are owned by Roivant Sciences Ltd. ("Roivant"). Roivant held 15,901,246 shares of OnCore which converted into 16,013,540 shares of the issuer in the Merger at the same conversion rate as described in footnote (1) herein. The reporting person is one of three directors of Roivant and may be deemed to have the power to vote and dispose of the shares owned by Roivant. The reporting person disclaims beneficial ownership of the shares owned by Roivant, except to the extent of his pecuniary interest therein. Exhibit List - Exhibit 24 - Power of Attorney /s/Alison Haggerty, Attorney-in-Fact 2015-03-16